SAINT PAUL, Minn., Dec. 27, 2012 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced that Gregg Lehman, chief executive officer and Rob Wolf, chief financial officer will present at the Sidoti & Company Annual New York Micro Cap Conference on Monday, January 7, 2013 at 1:30pm ET. The conference is being held at the Grand Hyatt New York Hotel in New York City.
MGC Diagnostics management will be available for one-on-one meetings with investors during the day at the conference. Investors interested in arranging one-on-one meetings, please contact your Sidoti representative or Lytham Partners at 602-889-9700.
About MGC Diagnostics
MGC Diagnostics Corporation (NASDAQ: MGCD), (formerly Angeion Corporation), is a global medical technology company dedicated to cardiorespiratory health solutions. MGC Diagnostics develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.
Robert M. Wolf
Joe Dorame, Robert Blum, Joe Diaz
MGC Diagnostics Corporation
Lytham Partners, LLC
Chief Financial Officer
SOURCE MGC Diagnostics Corporation